nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—ABCB1—peripheral nervous system neoplasm	0.436	1	CbGaD
Desloratadine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0565	0.138	CbGbCtD
Desloratadine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0494	0.12	CbGbCtD
Desloratadine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0494	0.12	CbGbCtD
Desloratadine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0474	0.115	CbGbCtD
Desloratadine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0452	0.11	CbGbCtD
Desloratadine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0343	0.0835	CbGbCtD
Desloratadine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0221	0.0539	CbGbCtD
Desloratadine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0211	0.0514	CbGbCtD
Desloratadine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0203	0.0494	CbGbCtD
Desloratadine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0197	0.048	CbGbCtD
Desloratadine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0193	0.0471	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0132	0.0321	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0124	0.0303	CbGbCtD
Desloratadine—Loratadine—ABCB1—peripheral nervous system neoplasm	0.000513	1	CrCbGaD
Desloratadine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.00034	0.00222	CcSEcCtD
Desloratadine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000339	0.0022	CcSEcCtD
Desloratadine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000339	0.0022	CcSEcCtD
Desloratadine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000336	0.00219	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000333	0.00217	CcSEcCtD
Desloratadine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00216	CcSEcCtD
Desloratadine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000332	0.00216	CcSEcCtD
Desloratadine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.00215	CcSEcCtD
Desloratadine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000329	0.00214	CcSEcCtD
Desloratadine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000329	0.00214	CcSEcCtD
Desloratadine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000326	0.00212	CcSEcCtD
Desloratadine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000326	0.00212	CcSEcCtD
Desloratadine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000325	0.00211	CcSEcCtD
Desloratadine—Infection—Vincristine—peripheral nervous system neoplasm	0.000324	0.00211	CcSEcCtD
Desloratadine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000323	0.0021	CcSEcCtD
Desloratadine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000323	0.0021	CcSEcCtD
Desloratadine—Increased appetite—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00209	CcSEcCtD
Desloratadine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000321	0.00209	CcSEcCtD
Desloratadine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000321	0.00209	CcSEcCtD
Desloratadine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00032	0.00208	CcSEcCtD
Desloratadine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000319	0.00207	CcSEcCtD
Desloratadine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000317	0.00207	CcSEcCtD
Desloratadine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000316	0.00206	CcSEcCtD
Desloratadine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000316	0.00206	CcSEcCtD
Desloratadine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000316	0.00206	CcSEcCtD
Desloratadine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000315	0.00205	CcSEcCtD
Desloratadine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000312	0.00203	CcSEcCtD
Desloratadine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000311	0.00202	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00201	CcSEcCtD
Desloratadine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000308	0.00201	CcSEcCtD
Desloratadine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000306	0.00199	CcSEcCtD
Desloratadine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000306	0.00199	CcSEcCtD
Desloratadine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000306	0.00199	CcSEcCtD
Desloratadine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.00199	CcSEcCtD
Desloratadine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.00196	CcSEcCtD
Desloratadine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000302	0.00196	CcSEcCtD
Desloratadine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00196	CcSEcCtD
Desloratadine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.00196	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000299	0.00194	CcSEcCtD
Desloratadine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.00194	CcSEcCtD
Desloratadine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000298	0.00194	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000297	0.00193	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00193	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000297	0.00193	CcSEcCtD
Desloratadine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000295	0.00192	CcSEcCtD
Desloratadine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000295	0.00192	CcSEcCtD
Desloratadine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000295	0.00192	CcSEcCtD
Desloratadine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000294	0.00192	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.0019	CcSEcCtD
Desloratadine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.0019	CcSEcCtD
Desloratadine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.00188	CcSEcCtD
Desloratadine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.00188	CcSEcCtD
Desloratadine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000289	0.00188	CcSEcCtD
Desloratadine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000289	0.00188	CcSEcCtD
Desloratadine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00187	CcSEcCtD
Desloratadine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000286	0.00186	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000286	0.00186	CcSEcCtD
Desloratadine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000284	0.00185	CcSEcCtD
Desloratadine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000284	0.00185	CcSEcCtD
Desloratadine—Rash—Topotecan—peripheral nervous system neoplasm	0.000284	0.00185	CcSEcCtD
Desloratadine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000284	0.00185	CcSEcCtD
Desloratadine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000284	0.00185	CcSEcCtD
Desloratadine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00184	CcSEcCtD
Desloratadine—Cough—Etoposide—peripheral nervous system neoplasm	0.000283	0.00184	CcSEcCtD
Desloratadine—Headache—Topotecan—peripheral nervous system neoplasm	0.000282	0.00184	CcSEcCtD
Desloratadine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00183	CcSEcCtD
Desloratadine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00183	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000282	0.00183	CcSEcCtD
Desloratadine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00183	CcSEcCtD
Desloratadine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000281	0.00183	CcSEcCtD
Desloratadine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.00183	CcSEcCtD
Desloratadine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000281	0.00183	CcSEcCtD
Desloratadine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000281	0.00183	CcSEcCtD
Desloratadine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00028	0.00182	CcSEcCtD
Desloratadine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00028	0.00182	CcSEcCtD
Desloratadine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00028	0.00182	CcSEcCtD
Desloratadine—Rash—Melphalan—peripheral nervous system neoplasm	0.000278	0.00181	CcSEcCtD
Desloratadine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000278	0.00181	CcSEcCtD
Desloratadine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000277	0.0018	CcSEcCtD
Desloratadine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000275	0.00179	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.00179	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000272	0.00177	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00027	0.00175	CcSEcCtD
Desloratadine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000269	0.00175	CcSEcCtD
Desloratadine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000269	0.00175	CcSEcCtD
Desloratadine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00174	CcSEcCtD
Desloratadine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.00174	CcSEcCtD
Desloratadine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000268	0.00174	CcSEcCtD
Desloratadine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000267	0.00174	CcSEcCtD
Desloratadine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000265	0.00173	CcSEcCtD
Desloratadine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.00173	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000264	0.00172	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.00172	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000263	0.00171	CcSEcCtD
Desloratadine—Infection—Etoposide—peripheral nervous system neoplasm	0.000263	0.00171	CcSEcCtD
Desloratadine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.00171	CcSEcCtD
Desloratadine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000262	0.0017	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000258	0.00168	CcSEcCtD
Desloratadine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000258	0.00168	CcSEcCtD
Desloratadine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000258	0.00168	CcSEcCtD
Desloratadine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00167	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.00164	CcSEcCtD
Desloratadine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000252	0.00164	CcSEcCtD
Desloratadine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000251	0.00163	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000251	0.00163	CcSEcCtD
Desloratadine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00163	CcSEcCtD
Desloratadine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.00162	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00162	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000249	0.00162	CcSEcCtD
Desloratadine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.00158	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000242	0.00158	CcSEcCtD
Desloratadine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00024	0.00156	CcSEcCtD
Desloratadine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00024	0.00156	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000236	0.00153	CcSEcCtD
Desloratadine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000235	0.00153	CcSEcCtD
Desloratadine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000234	0.00152	CcSEcCtD
Desloratadine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00151	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000232	0.00151	CcSEcCtD
Desloratadine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000232	0.00151	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.00151	CcSEcCtD
Desloratadine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00151	CcSEcCtD
Desloratadine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.0015	CcSEcCtD
Desloratadine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00023	0.0015	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000228	0.00149	CcSEcCtD
Desloratadine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000228	0.00148	CcSEcCtD
Desloratadine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000228	0.00148	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00147	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00146	CcSEcCtD
Desloratadine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000224	0.00146	CcSEcCtD
Desloratadine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000223	0.00145	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00022	0.00143	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00143	CcSEcCtD
Desloratadine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000217	0.00141	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000216	0.00141	CcSEcCtD
Desloratadine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000216	0.0014	CcSEcCtD
Desloratadine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.0014	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.0014	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.0014	CcSEcCtD
Desloratadine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00139	CcSEcCtD
Desloratadine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.00139	CcSEcCtD
Desloratadine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000213	0.00138	CcSEcCtD
Desloratadine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000212	0.00138	CcSEcCtD
Desloratadine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00021	0.00137	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000209	0.00136	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000209	0.00136	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00136	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000209	0.00136	CcSEcCtD
Desloratadine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000207	0.00135	CcSEcCtD
Desloratadine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000207	0.00135	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000207	0.00135	CcSEcCtD
Desloratadine—Rash—Vincristine—peripheral nervous system neoplasm	0.000206	0.00134	CcSEcCtD
Desloratadine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000206	0.00134	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00133	CcSEcCtD
Desloratadine—Headache—Vincristine—peripheral nervous system neoplasm	0.000204	0.00133	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00132	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00132	CcSEcCtD
Desloratadine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00131	CcSEcCtD
Desloratadine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000197	0.00128	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000195	0.00127	CcSEcCtD
Desloratadine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000194	0.00126	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00126	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.00126	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.00125	CcSEcCtD
Desloratadine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00019	0.00123	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.00123	CcSEcCtD
Desloratadine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000187	0.00122	CcSEcCtD
Desloratadine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000183	0.00119	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000183	0.00119	CcSEcCtD
Desloratadine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00118	CcSEcCtD
Desloratadine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00118	CcSEcCtD
Desloratadine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00118	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000181	0.00118	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00117	CcSEcCtD
Desloratadine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000175	0.00114	CcSEcCtD
Desloratadine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.00112	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.0011	CcSEcCtD
Desloratadine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000168	0.00109	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.00109	CcSEcCtD
Desloratadine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00109	CcSEcCtD
Desloratadine—Rash—Etoposide—peripheral nervous system neoplasm	0.000167	0.00108	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000166	0.00108	CcSEcCtD
Desloratadine—Headache—Etoposide—peripheral nervous system neoplasm	0.000166	0.00108	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00104	CcSEcCtD
Desloratadine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000158	0.00103	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000157	0.00102	CcSEcCtD
Desloratadine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000157	0.00102	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00101	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.001	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000984	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000966	CcSEcCtD
Desloratadine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000964	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000964	CcSEcCtD
Desloratadine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000958	CcSEcCtD
Desloratadine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000954	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000947	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000946	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000941	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000931	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000919	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00091	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000892	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000892	CcSEcCtD
Desloratadine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000886	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000879	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000875	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000872	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000871	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00086	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000857	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.00085	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000849	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000838	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000832	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000831	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000813	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000807	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000795	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000793	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000788	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000785	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000776	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00077	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000769	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000766	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000762	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000762	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00073	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00071	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000709	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000705	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000705	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000692	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000682	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00066	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000657	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.00064	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000638	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.7e-05	0.000631	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000613	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.00061	CcSEcCtD
Desloratadine—Rash—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000608	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.33e-05	0.000607	CcSEcCtD
Desloratadine—Headache—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000604	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.00059	CcSEcCtD
Desloratadine—Nausea—Epirubicin—peripheral nervous system neoplasm	8.8e-05	0.000573	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.72e-05	0.000567	CcSEcCtD
Desloratadine—Rash—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000563	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000562	CcSEcCtD
Desloratadine—Headache—Doxorubicin—peripheral nervous system neoplasm	8.59e-05	0.000559	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.00053	CcSEcCtD
